Cargando…

Plasma-Free Amino Acid Profiles in Crohn’s Disease: Relationship With the Crohn Disease Activity Index

We aimed to clarify the relationship between plasma-free amino acid (PFAA) profiles and the Crohn’s disease (CD) activity index (CDAI) in patients with CD. METHODS: We measured fasting PFAA concentrations in 29 patients with CD and their correlation with disease activity. RESULTS: In all patients, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiba, Toshimi, Suzuki, Kazuyuki, Matsumoto, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066806/ https://www.ncbi.nlm.nih.gov/pubmed/30083065 http://dx.doi.org/10.1177/1179552218791173

Ejemplares similares

Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy
por: Chiba, Toshimi, et al.
Publicado: (2019)

Amino acid profiles, disease activity, and protein intake in adult patients with Crohn’s disease
por: Cioffi, Iolanda, et al.
Publicado: (2023)

Evaluation of Infliximab Effects on Gastrointestinal Bleeding in Crohn's Disease Using Double-Balloon Endoscopy
por: Chowdhury, Manzurul, et al.
Publicado: (2009)

Amino acid-responsive Crohn’s disease: a case study
por: Stein, Alvin, et al.
Publicado: (2010)

Evaluation of the modified Crohn's disease activity index in patients with Crohn disease with enterostomy: A single-center observational study
por: Ishida, Natsuki, et al.
Publicado: (2021)

Peripheral Blood CD64 Levels Decrease in Crohn's Disease following Granulocyte and Monocyte Adsorptive Apheresis
por: Chiba, Toshimi, et al.
Publicado: (2011)

Amino Acid-Responsive Crohn’s Disease: A Case Study [Retraction]
Publicado: (2020)

Familial Mediterranean fever mimicking Crohn disease: A case report
por: Asakura, Kensuke, et al.
Publicado: (2018)

Biologics and surgical outcomes in Crohn’s disease: is there a direct relationship?
por: Quaresma, Abel Botelho, et al.
Publicado: (2020)

Plasma miRNA Profile of Crohn’s Disease and Rheumatoid Arthritis Patients
por: Saccon, Tatiana D., et al.
Publicado: (2022)

Amino Acid-Responsive Crohn’s Disease: A Case Study [Expression of Concern]
Publicado: (2020)

Alterations of Serum Bile Acid Profile in Patients with Crohn's Disease
por: Sun, Rui, et al.
Publicado: (2022)

Nutrient Intake of Crohn’s Patients: Is There Consistency between Crohn’s Disease Activity Index, Subjective Global Assessment and Body Mass Index?
por: İnanç, Neriman, et al.
Publicado: (2021)

Value of Computerized Tomography Enterography in Predicting Crohn’s Disease Activity: Correlation with Crohn’s Disease Activity Index and C-Reactive Protein
por: Park, Eun Kyung, et al.
Publicado: (2016)

CROHN'S DISEASE
Publicado: (1972)

Crohn disease
por: Geller, Stephen A, et al.
Publicado: (2015)

Crohn's Disease
Publicado: (1973)

Is It Crohn’s Disease?
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2020)

Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
por: Bamba, Shigeki, et al.
Publicado: (2022)

Impaired cognitive function in Crohn’s disease: Relationship to disease activity
por: Clarke, Gerard, et al.
Publicado: (2020)

The relationship of major depressive disorder with Crohn's disease activity
por: Facanali, Carolina Bortolozzo Graciolli, et al.
Publicado: (2023)

A Novel Capsule Endoscopic Score for Crohn’s Disease
por: Omori, Teppei, et al.
Publicado: (2020)

Serum Cytokine Profiles in Children with Crohn's Disease
por: Vasilyeva, Ekaterina, et al.
Publicado: (2016)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission
por: Miyazu, Takahiro, et al.
Publicado: (2021)

Characterization of gut microbiota profiles by disease activity in patients with Crohn’s disease using data mining analysis of terminal restriction fragment length polymorphisms
por: ANDOH, AKIRA, et al.
Publicado: (2014)

Lipid and Bile Acid Dysmetabolism in Crohn's Disease
por: Uchiyama, Koji, et al.
Publicado: (2018)

Immunotherapy of Crohn's disease.
por: van Montfrans, C, et al.
Publicado: (1998)

Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007)

Oropharyngeal Crohn’s disease
por: Mohamed, Rachid, et al.
Publicado: (2008)

Oral Crohn's disease
por: Padmavathi, BN, et al.
Publicado: (2014)

Crohn’s disease in women
por: Plavšić, Ivana, et al.
Publicado: (2013)

Telocytes in Crohn’s disease
por: Milia, Anna Franca, et al.
Publicado: (2013)

Metastatic Crohn's disease
por: Lanka, Padmavathy, et al.
Publicado: (2014)

Pathogenesis of Crohn's disease
por: Boyapati, Ray, et al.
Publicado: (2015)

Metastatic Crohn's disease
por: Miguel, Pérez-Belmonte Luis, et al.
Publicado: (2015)

Management of Crohn's disease
por: Kammermeier, Jochen, et al.
Publicado: (2016)

Urolithiasis and crohn's disease
por: Gaspar, Sandro Roberto da Silva, et al.
Publicado: (2016)

Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)

The History of Crohn's Disease
por: Banerjee, Anjan K., et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_2fd567r5pmg3ah8bn91ci2e92p